Have any questions? 706-721-6582 or cts@augusta.edu
| Study Name | Principal Investigator |
|---|---|
| KO-MEN-008 Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia | Cortes, Jorge |
RESEARCH. INNOVATION. DISCOVERY.